Traditional Chinese medicine

Traditional Chinese medicines include anti-tumor medicine “Shenqi Fuzheng Injection” and cold medicine “Antiviral Oral Granule”.

In recent years, under the active promotion of many favorable policies of the state, the Chinese medicine industry has gained tremendous room for development. According to the Twelfth Five-Year Plan for the Development of Traditional Chinese Medicine, the development goal of the Chinese medicine industry is: by 2020, the main business income of Chinese medicine enterprises above designated size reaches 1,582.3 billion yuan, with a compound annual growth rate of 15%. The Shenqi Fuzheng Injection and Antiviral Oral Granule manufactured by the company’s holding subsidiary, Livzon Group, are representatives of the company’s traditional Chinese medicine products.